ProShares Ultra S&P500 (SSO)
Bay Colony Advisory Group Inc d b a Bay Colony Advisors Takes $1.32 Million Position in ProShares Ultra S&P500 $SSO
Bay Colony Advisory Group Inc d b a Bay Colony Advisors bought a new stake in shares of ProShares Ultra S&P500 (NYSEARCA:SSO) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 19,662 shares of the real estate investment trust's stock, valued at
Leveraged ETF Dashboard And SSO History
The ProShares Ultra S&P500 ETF offers 2X leverage on the S&P 500, making it a strong swing trading instrument but vulnerable to long-term decay. SSO's drift is marginally negative over both 1-month and 1-year periods, with decay driven mainly by beta-slippage and market volatility. SSO has outperformed SPY in long-term annualized return but lags on risk-adjusted returns due to higher volatility and negative drift.
OpenEvidence and Society of Surgical Oncology Announce Strategic Partnership to Advance Surgical Cancer Care and Launch SSO Innovator Grant
MIAMI & ROSEMONT, Ill.--(BUSINESS WIRE)-- #MedicalAI--Today, the Society of Surgical Oncology (SSO), a global professional society for cancer surgeons, and OpenEvidence, the most widely used medical knowledge platform, announced a strategic partnership to strengthen access to the most trusted surgical oncology evidence at the point of care while building a foundation for innovative collaborations to support surgeons and all physicians taking care of patients with cancer. Together, SSO and OpenEvidence will.
Chicago Partners Investment Group LLC Acquires 9,320 Shares of ProShares Ultra S&P500 $SSO
Chicago Partners Investment Group LLC increased its holdings in shares of ProShares Ultra S&P500 (NYSEARCA:SSO) by 100.4% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,605 shares of the real estate investment trust's stock after buying an
Berger Financial Group Inc Grows Stock Position in ProShares Ultra S&P500 $SSO
Berger Financial Group Inc raised its holdings in ProShares Ultra S&P500 (NYSEARCA:SSO) by 98.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 22,730 shares of the real estate investment trust's stock after buying an additional 11,286 shares during the quarter. Berger
SSO vs. SPYM: Which Is the Best Way to Buy the S&P 500?
The State Street SPDR Portfolio S&P 500 ETF has delivered an annualized return of 14.2% for the past 10 years. With the power of leverage, the SSO Ultra S&P 500 ETF has achieved higher gains of 21.2% annually in that time.
Could Investing $10,000 in This Leveraged ETF Make You a Millionaire?
The ProShares Ultra S&P 500 is a leveraged exchange-traded fund (ETF) that has delivered average annual returns of 14.5% over nearly 20 years. The fund uses leverage (debt) and aims to double the daily performance of the S&P 500 index.
Arta Finance Wealth Management LLC Takes $8.49 Million Position in ProShares Ultra S&P500 $SSO
Arta Finance Wealth Management LLC bought a new position in shares of ProShares Ultra S&P500 (NYSEARCA:SSO) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 146,602 shares of the real estate investment trust's stock, valued at
SSO Offers Lower Risk Than TQQQ for Leveraged ETF Traders
TQQQ and SSO both offer leveraged exposure, but TQQQ amplifies the Nasdaq-100 by 3x daily while SSO provides 2x daily S&P 500 returns. TQQQ's higher leverage brings a deeper max drawdown and more volatility, while SSO's risk is comparatively lower but still significant.
Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma's i31-SLNB, Identifying T1b–T2a Melanoma Patients Who May Safely Avoid SLNB
Castle will share new data evaluating DecisionDx-Melanoma's i31-SLNB test result for prediction of sentinel lymph node (SLN) positivity at SSO 2026.
Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation
THE WOODLANDS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Clarke Wilkirson, PhD, Clinical Development Engineer II, will present new long-term clinical data at the Society of Surgical Oncology (SSO) 2026 Annual Meeting, happening March 5-7, 2026, in Phoenix, Arizona.
Leveraged ETFs Are Not Long-Term Holdings. Here's Why.
Leveraged ETFs promise supercharged gains. The math tells a different story.
The 2x Leveraged SSO ETF Can Double Your Returns, Until Volatility Strikes
If the market goes up 1%, a leveraged ETF promises to go up 2%. That sounds like free money until you understand the catch: daily rebalancing means the math only works in one direction at a time.
Silver Standard Resources (SSRM) to Release Quarterly Earnings on Tuesday
Silver Standard Resources (NASDAQ: SSRM - Get Free Report) (TSE: SSO) will likely be posting its Q4 2025 results after the market closes on Tuesday, February 17th. Analysts expect the company to announce earnings of $0.74 per share and revenue of $436.2290 million for the quarter. Investors are encouraged to explore the company's upcoming Q4 2025 earning
ProShares Ultra S&P500 (NYSEARCA:SSO) Share Price Pass Above 200 Day Moving Average – What’s Next?
ProShares Ultra S&P500 (NYSEARCA:SSO - Get Free Report) passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $55.28 and traded as high as $58.22. ProShares Ultra S&P500 shares last traded at $56.99, with a volume of 7,566,666 shares changing hands. ProShares Ultra S&P500 Stock Down
ProShares Ultra S&P500 (NYSEARCA:SSO) Shares Pass Above 200-Day Moving Average – Time to Sell?
Shares of ProShares Ultra S&P500 (NYSEARCA:SSO - Get Free Report) crossed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $53.31 and traded as high as $57.99. ProShares Ultra S&P500 shares last traded at $57.91, with a volume of 2,535,288 shares. ProShares
ProShares Ultra S&P500 (NYSEARCA:SSO) Stock Pass Above Two Hundred Day Moving Average – What’s Next?
ProShares Ultra S&P500 (NYSEARCA:SSO - Get Free Report)'s stock price passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of $52.77 and traded as high as $59.16. ProShares Ultra S&P500 shares last traded at $59.15, with a volume of 2,807,710 shares changing
Leveraged ETF Watchlist And Focus On SSO's Decay
ProShares Ultra S&P 500 ETF offers 2X leverage on the S&P 500, making it a potential swing trading tool but subject to performance drift. SSO and other leveraged ETFs experience decay, primarily due to beta slippage, which worsens with higher volatility and leverage factors. Historical data shows SSO's 12-month drift has been almost permanently negative since January 2022, highlighting risks in volatile markets.
SecurityBridge Acquires CyberSafe To Deliver Contextual SSO, MFA, And Passwordless Authentication To SAP Users
NEW YORK--(BUSINESS WIRE)-- #SecurityBridge--SecurityBridge, the creator of the Cybersecurity Command Center for SAP, today announced the acquisition of CyberSafe, a UK-based pioneer in multi-factor authentication (MFA) and single sign-on (SSO) solutions for SAP users. The acquisition marks a significant milestone in SAP security innovation, as CyberSafe's flagship TrustBroker® products will further enrich the SecurityBridge platform capabilities. A two-way integration enables customers to transition from passwo.
SSO: Good For Short-Term Tactical Exposure To S&P 500 Upside
We are bullish on the S&P 500 due to positive market catalysts like potential Fed rate cuts and progress on trade deals. The ProShares Ultra S&P500 ETF offers leveraged exposure, amplifying both gains and losses, making it suitable for tactical, short-term trades. Current S&P 500 valuations are historically high, increasing risk, especially when combined with the compounding effects of leverage and volatility.